You are here » Home » Companies » Company Overview » Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Ltd.

BSE: 524711 Sector: Health care
NSE: N.A. ISIN Code: INE427C01021
BSE LIVE 15:45 | 15 Dec 42.00 -0.35
(-0.83%)
OPEN

40.25

HIGH

43.25

LOW

40.25

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 40.25
PREVIOUS CLOSE 42.35
VOLUME 13638
52-Week high 54.15
52-Week low 15.85
P/E 77.78
Mkt Cap.(Rs cr) 120
Buy Price 42.00
Buy Qty 907.00
Sell Price 0.00
Sell Qty 0.00
OPEN 40.25
CLOSE 42.35
VOLUME 13638
52-Week high 54.15
52-Week low 15.85
P/E 77.78
Mkt Cap.(Rs cr) 120
Buy Price 42.00
Buy Qty 907.00
Sell Price 0.00
Sell Qty 0.00

Vista Pharmaceuticals Ltd. (VISTAPHARMA) - Company History

Vista Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the formulation of pharmaceutical products. The company offers a range of products mainly in the therapeutic areas of gastrointestinal, pain management and anti-infective, catering to common ailments. This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd. The company is based in Hyderabad, India. Vista Pharmaceuticals Limited was incorporated on January 25,1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli & his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of State of New Jersy, United States of America. During the fiscal year ended March 31, 2010 (fiscal 2010), the Company obtained the United States Food and Drug Administration (FDA) approval for the manufacture of Bactrim generic product. During fiscal 2010, the Company produced 20.488 million numbers of tablets. The Company was in process of setting up a 100% EOU for manufcacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum.